会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • PYRAZOLON DERIVATIVES AS INHIBITORS OF GSK-3
    • 作为GSK-3的抑制剂的吡唑啉衍生物
    • WO2003011287A1
    • 2003-02-13
    • PCT/US2002/024726
    • 2002-08-02
    • VERTEX PHARMACEUTICALS INCORPORATEDGREEN, JeremyARNOST, Michael, J.PIERCE, Albert
    • GREEN, JeremyARNOST, Michael, J.PIERCE, Albert
    • A61K31/415
    • C07D401/12C07D231/20C07D231/46C07D403/12C07D405/12C07D409/12
    • The present invention relates to compounds of formula (I) that are useful as GSK-3 inhibitors. The invention also relates to methods of using compounds of formula (I) or pharmaceutical compositions comprising compounds of formula (I) to inhibit GSK-3 activity. The invention further provides methods of utilizing these compounds and pharmaceutical compositions in the treatment and prevention of various disorders, such as diabetes and Alzheimer's disease. The invention also relates to methods for inhibiting Aurora-2 activity and for treating or preventing Aurora-2-mediated diseases using compounds of formula (I) or pharmaceutical compositions comprising compounds of formula (I). The invention also relates to methods for inhibiting cyclin-dependent kinase-2 activity and for treating or preventing inhibiting cyclin-dependent kinase-2-mediated diseases using compounds of formula (I) or pharmaceutical compositions comprising compounds of formula (I).
    • 本发明涉及可用作GSK-3抑制剂的式(I)化合物。 本发明还涉及使用式(I)化合物或包含式(I)化合物的药物组合物抑制GSK-3活性的方法。 本发明还提供了利用这些化合物和药物组合物治疗和预防各种疾病如糖尿病和阿尔茨海默病的方法。 本发明还涉及使用式(I)化合物或包含式(I)化合物的药物组合物来抑制Aurora-2活性和治疗或预防Aurora-2介导的疾病的方法。 本发明还涉及使用式(I)化合物或包含式(I)化合物的药物组合物来抑制细胞周期蛋白依赖性激酶-2活性和治疗或预防抑制细胞周期蛋白依赖性激酶2介导的疾病的方法。
    • 8. 发明申请
    • INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES
    • GSK-3β蛋白和蛋白复合物的GSK-3和晶体结构的抑制剂
    • WO2002088078A2
    • 2002-11-07
    • PCT/US2002/013511
    • 2002-04-29
    • VERTEX PHARMACEUTICALS INCORPORATEDTER HAAR, ErnstSWENSON, LovorkaGREEN, JeremyARNOST, Michael, J.
    • TER HAAR, ErnstSWENSON, LovorkaGREEN, JeremyARNOST, Michael, J.
    • C07D
    • C07D487/04C07K2299/00C12N9/1205G06F19/16
    • The present invention relates to inhibitors of GSK-3 and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors and methods of utilizing those compositions in the treatment and prevention of various disorders, such as diabetes and Alzheimer's disease. In addition, the invention relates to molecules or molecular complexes which comprise binding pockets of GSK-3β or its homologues. The invention relates to a computer comprising a data storage medium encoded with the structure coordinates of such binding pockets. The invention also relates to methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. The invention relates to methods of using the structure coordinates to screen for and design compounds that bind to GSK-3β protein or homologues thereof. The invention also relates to crystallizable compositions and crystals comprising GSK-3β protein or GSK-3β protein complexes.
    • 本发明涉及GSK-3抑制剂及其制备方法。 本发明还提供包含抑制剂的药物组合物和利用这些组合物治疗和预防各种疾病如糖尿病和阿尔茨海默氏病的方法。 此外,本发明涉及包含GSK-3β或其同源物的结合口袋的分子或分子复合物。 本发明涉及一种计算机,包括用这种结合口袋的结构坐标编码的数据存储介质。 本发明还涉及使用结构坐标来解决同源蛋白质或蛋白质复合物的结构的方法。 本发明涉及使用结构坐标筛选和设计结合GSK-3β蛋白或其同系物的化合物的方法。 本发明还涉及可结晶组合物和包含GSK-3β蛋白或GSK-3β蛋白复合物的晶体。